title: Localization of a fibrillar amyloid beta-protein binding domain on its precursor.
abstract: Deposition of fibrillar amyloid-beta protein (Abeta) in senile plaques and in the walls of cerebral blood vessels is a key pathological feature of Alzheimer's disease and certain related disorders. Fibrillar Abeta deposition is intimately associated with neuronal and cerebrovascular cell death both in vivo and in vitro. Similarly, accumulation of the Abeta protein precursor (AbetaPP) is also observed at sites of fibrillar Abeta deposition. Recently, we reported that fibrillar Abeta, but not unassembled Abeta, promotes the specific binding of AbetaPP through its cysteine-rich, amino-terminal region (Melchor, J. P., and Van Nostrand, W. E. (2000) J. Biol. Chem. 275, 9782-9791). In the present study we sought to determine the precise site on AbetaPP that facilitates its binding to fibrillar Abeta. A series of synthesized overlapping peptides spanning the cysteine-rich, amino-terminal region of AbetaPP were used as competitors for AbetaPP binding to fibrillar Abeta. A peptide spanning residues 105-119 of AbetaPP competitively inhibited AbetaPP binding to fibrillar Abeta in a solid-phase binding assay and on the surface of cultured human cerebrovascular smooth muscle cells. Alanine-scanning mutagenesis of residues 105-117 within glutathione S-transferase (GST)-AbetaPP-(18-119) revealed that His(110), Val(112), and Ile(113) are key residues that facilitate AbetaPP binding to fibrillar Abeta. These specific residues belong to a common beta-strand within this region of AbetaPP. Wild-type GST-AbetaPP-(18-119) protected cultured human cerebrovascular smooth muscle cells from Abeta-induced toxicity whereas H110A mutant GST-AbetaPP-(18-119) did not. Wild-type GST-AbetaPP-(18-119) bound to different isoforms of fibrillar Abeta and fibrillar amylin peptides whereas H110A mutant and I113A mutant GST-AbetaPP-(18-119) were substantially less efficient binding to each fibrillar peptide. We conclude that His(110), Val(112), and Ile(113), residing in a common beta-strand region within AbetaPP-(18-119), comprise a domain that mediates the binding of AbetaPP to fibrillar peptides.
authors.affiliation: Department of Medicine, Health Sciences Center, Stony Brook University, Stony Brook, New York 11794-8153, USA. William.VanNostrand@stonybrook.edu
authors.forename: William E
authors.initials: WE
authors.lastname: Van Nostrand
authors.forename: Jerry P
authors.initials: JP
authors.lastname: Melchor
authors.forename: David M
authors.initials: DM
authors.lastname: Keane
authors.forename: Susan M
authors.initials: SM
authors.lastname: Saporito-Irwin
authors.forename: Galina
authors.initials: G
authors.lastname: Romanov
authors.forename: Judianne
authors.initials: J
authors.lastname: Davis
authors.forename: Feng
authors.initials: F
authors.lastname: Xu
mesh_terms: D000409:Alanine / Q000378:metabolism; D000595:Amino Acid Sequence; D000682:Amyloid / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D001665:Binding Sites; D016923:Cell Death; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology; D004926:Escherichia coli / Q000378:metabolism; D005091:Exons; D006801:Humans; D058228:Islet Amyloid Polypeptide; D007700:Kinetics; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009130:Muscle, Smooth / Q000166:cytology; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology; D010455:Peptides / Q000378:metabolism; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D017386:Sequence Homology, Amino Acid
chemical_list: D000682:Amyloid; D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D058228:Islet Amyloid Polypeptide; D010446:Peptide Fragments; D010455:Peptides; C078592:amyloid beta-protein (1-40); D000409:Alanine